Animal study · rats
MOTS-c improved heart mitochondrial respiration in diabetic rats
Checked against the paper Animal studyPublished by PepVault
The takeaway
This rat study links MOTS-c to better glucose control and stronger heart mitochondrial respiration in diabetes, but it is early animal evidence only.
- Kind
- Animal study
- Studied in
- Rats
- Published
- 2025
- Journal
- Front Physiol
What they tested
The team wanted to know whether MOTS-c treatment improves energy production by heart mitochondria, the cell's power units, in type 2 diabetes.
How the study was done
An animal study in rats made diabetic with a high-fat diet and low-dose streptozotocin, compared with healthy control rats. One diabetic group got daily MOTS-c injections at 15 mg/kg for 3 weeks, and heart tissue samples were tested for oxygen use, ATP (the cell's energy molecule) handling and ROS (reactive oxygen species) output.

What they found
In rats, untreated diabetic animals had high blood sugar, poor glucose control and left ventricular hypertrophy (an enlarged main pumping chamber wall) compared with controls. Their heart mitochondria used less oxygen during oxidative phosphorylation (the main energy-making step), while ROS output and ATP production and breakdown did not change. Diabetic rats given MOTS-c had lower fasting glucose, better glucose control and less heart enlargement. Their heart mitochondria showed higher oxidative phosphorylation respiration, higher ROS levels and a lower rate of ATP breakdown when oxygen was cut off.
What it doesn’t show
This is a short, 3-week study in rats with a diet-and-drug model of diabetes, so it is not a human result. The mitochondrial tests were done on heart tissue samples, so the study does not show effects on heart pumping in living animals or people.
The paper
Pham et al. Mitochondria-derived peptide MOTS-c restores mitochondrial respiration in type 2 diabetic heart. Front Physiol. 2025.
The compound
More studies on MOTS-c
- MOTS-c rose after 16 weeks of exercise in non-Hispanic White survivorsRandomized trial · people · 2021
- MOTS-c reduced islet cell senescence and glucose intolerance in miceAnimal study · mice · 2025
- MOTS-c eased lung ischemia-reperfusion injury and deaths in ratsAnimal study · rats · 2025
- MOTS-c prevented muscle atrophy, raised muscle glucose uptake in miceAnimal study · mice · 2024
- MOTS-c raised testosterone, LH and FSH in obese and non-obese ratsAnimal study · rats · 2024
- MOTS-c improved heart small-vessel barrier under endotoxin in miceAnimal study · mice · 2024
- Every study on MOTS-c
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.